Clinical Trial Update: Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether oral glutamine reduces mucositis in head and neck cancer patients undergoing radiation; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Mucositis

Drugs mentioned

• Oral glutamine (glutamine)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Head and Neck Cancer, Mucositis | Phase 3 | Status: UNKNOWN